Electroencephalographic Cross-Frequency Coupling as a Sign of Disease Progression in Patients With Mild Cognitive Impairment: A Pilot Study

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Electroencephalographic Cross-Frequency Coupling as a Sign of Disease Progression in Patients With Mild Cognitive Impairment : A Pilot Study. / Musaeus, Christian Sandøe; Nielsen, Malene Schjønning; Musaeus, Jørgen Sandøe; Høgh, Peter.

I: Frontiers in Neuroscience, Bind 14, 790, 11.08.2020.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Musaeus, CS, Nielsen, MS, Musaeus, JS & Høgh, P 2020, 'Electroencephalographic Cross-Frequency Coupling as a Sign of Disease Progression in Patients With Mild Cognitive Impairment: A Pilot Study', Frontiers in Neuroscience, bind 14, 790. https://doi.org/10.3389/fnins.2020.00790

APA

Musaeus, C. S., Nielsen, M. S., Musaeus, J. S., & Høgh, P. (2020). Electroencephalographic Cross-Frequency Coupling as a Sign of Disease Progression in Patients With Mild Cognitive Impairment: A Pilot Study. Frontiers in Neuroscience, 14, [790]. https://doi.org/10.3389/fnins.2020.00790

Vancouver

Musaeus CS, Nielsen MS, Musaeus JS, Høgh P. Electroencephalographic Cross-Frequency Coupling as a Sign of Disease Progression in Patients With Mild Cognitive Impairment: A Pilot Study. Frontiers in Neuroscience. 2020 aug. 11;14. 790. https://doi.org/10.3389/fnins.2020.00790

Author

Musaeus, Christian Sandøe ; Nielsen, Malene Schjønning ; Musaeus, Jørgen Sandøe ; Høgh, Peter. / Electroencephalographic Cross-Frequency Coupling as a Sign of Disease Progression in Patients With Mild Cognitive Impairment : A Pilot Study. I: Frontiers in Neuroscience. 2020 ; Bind 14.

Bibtex

@article{99a65fc2aaf645ad9c1275658648e343,
title = "Electroencephalographic Cross-Frequency Coupling as a Sign of Disease Progression in Patients With Mild Cognitive Impairment: A Pilot Study",
abstract = "Mild cognitive impairment (MCI) refers to mild objective cognitive deficits and is associated with the later development of Alzheimer's disease (AD). However, not all patients with MCI convert to AD. EEG spectral power has shown promise as a marker of progression, but brain oscillations in different frequencies are not isolated entities. Coupling between different frequency bands, so-called cross-frequency coupling (CFC), has been associated with memory function and may further contribute to our understanding of what characterizes patients with MCI who progress to AD. In the current study, we wanted to investigate the changes in gamma/theta CFC in patients with AD and MCI compared to HC and in patients with pMCI compared to patients with sMCI. Furthermore, we wanted to investigate the association with cognitive test scores. EEGs were included at baseline for 15 patients with AD, 25 patients with MCI, and 36 older HC, and the participants were followed for up to 3 years. To investigate CFC, we calculated the modulation index (MI), which has been shown to be less affected by noisy data compared to other techniques. We found that patients with pMCI showed a significantly lower global gamma/theta CFC compared to patients with sMCI. In addition, global gamma/theta CFC was significantly correlated with Addenbrooke's Cognitive Examination (ACE) score (p-value = 0.030, rho = 0.527). Although not significant, patients with AD and MCI showed a lower gamma/theta CFC compared to HC. These findings suggest that gamma/theta CFC is important for proper cognitive functioning and that a decrease in gamma/theta CFC in patients with MCI may be a sign of progression. Gamma/theta CFC may therefore serve as a progression marker in MCI, but larger studies are needed to validate these findings.",
keywords = "mild cognitive impairment, Alzheimer's disease, cross-frequency coupling, phase-amplitude coupling, gamma, theta, ALZHEIMERS-DISEASE, WORKING-MEMORY, EEG DYNAMICS, DEMENTIA, OSCILLATIONS, CONVERSION, DIAGNOSIS",
author = "Musaeus, {Christian Sand{\o}e} and Nielsen, {Malene Schj{\o}nning} and Musaeus, {J{\o}rgen Sand{\o}e} and Peter H{\o}gh",
year = "2020",
month = aug,
day = "11",
doi = "10.3389/fnins.2020.00790",
language = "English",
volume = "14",
journal = "Frontiers in Neuroscience",
issn = "1662-4548",
publisher = "Frontiers Research Foundation",

}

RIS

TY - JOUR

T1 - Electroencephalographic Cross-Frequency Coupling as a Sign of Disease Progression in Patients With Mild Cognitive Impairment

T2 - A Pilot Study

AU - Musaeus, Christian Sandøe

AU - Nielsen, Malene Schjønning

AU - Musaeus, Jørgen Sandøe

AU - Høgh, Peter

PY - 2020/8/11

Y1 - 2020/8/11

N2 - Mild cognitive impairment (MCI) refers to mild objective cognitive deficits and is associated with the later development of Alzheimer's disease (AD). However, not all patients with MCI convert to AD. EEG spectral power has shown promise as a marker of progression, but brain oscillations in different frequencies are not isolated entities. Coupling between different frequency bands, so-called cross-frequency coupling (CFC), has been associated with memory function and may further contribute to our understanding of what characterizes patients with MCI who progress to AD. In the current study, we wanted to investigate the changes in gamma/theta CFC in patients with AD and MCI compared to HC and in patients with pMCI compared to patients with sMCI. Furthermore, we wanted to investigate the association with cognitive test scores. EEGs were included at baseline for 15 patients with AD, 25 patients with MCI, and 36 older HC, and the participants were followed for up to 3 years. To investigate CFC, we calculated the modulation index (MI), which has been shown to be less affected by noisy data compared to other techniques. We found that patients with pMCI showed a significantly lower global gamma/theta CFC compared to patients with sMCI. In addition, global gamma/theta CFC was significantly correlated with Addenbrooke's Cognitive Examination (ACE) score (p-value = 0.030, rho = 0.527). Although not significant, patients with AD and MCI showed a lower gamma/theta CFC compared to HC. These findings suggest that gamma/theta CFC is important for proper cognitive functioning and that a decrease in gamma/theta CFC in patients with MCI may be a sign of progression. Gamma/theta CFC may therefore serve as a progression marker in MCI, but larger studies are needed to validate these findings.

AB - Mild cognitive impairment (MCI) refers to mild objective cognitive deficits and is associated with the later development of Alzheimer's disease (AD). However, not all patients with MCI convert to AD. EEG spectral power has shown promise as a marker of progression, but brain oscillations in different frequencies are not isolated entities. Coupling between different frequency bands, so-called cross-frequency coupling (CFC), has been associated with memory function and may further contribute to our understanding of what characterizes patients with MCI who progress to AD. In the current study, we wanted to investigate the changes in gamma/theta CFC in patients with AD and MCI compared to HC and in patients with pMCI compared to patients with sMCI. Furthermore, we wanted to investigate the association with cognitive test scores. EEGs were included at baseline for 15 patients with AD, 25 patients with MCI, and 36 older HC, and the participants were followed for up to 3 years. To investigate CFC, we calculated the modulation index (MI), which has been shown to be less affected by noisy data compared to other techniques. We found that patients with pMCI showed a significantly lower global gamma/theta CFC compared to patients with sMCI. In addition, global gamma/theta CFC was significantly correlated with Addenbrooke's Cognitive Examination (ACE) score (p-value = 0.030, rho = 0.527). Although not significant, patients with AD and MCI showed a lower gamma/theta CFC compared to HC. These findings suggest that gamma/theta CFC is important for proper cognitive functioning and that a decrease in gamma/theta CFC in patients with MCI may be a sign of progression. Gamma/theta CFC may therefore serve as a progression marker in MCI, but larger studies are needed to validate these findings.

KW - mild cognitive impairment

KW - Alzheimer's disease

KW - cross-frequency coupling

KW - phase-amplitude coupling

KW - gamma

KW - theta

KW - ALZHEIMERS-DISEASE

KW - WORKING-MEMORY

KW - EEG DYNAMICS

KW - DEMENTIA

KW - OSCILLATIONS

KW - CONVERSION

KW - DIAGNOSIS

U2 - 10.3389/fnins.2020.00790

DO - 10.3389/fnins.2020.00790

M3 - Journal article

C2 - 32848563

VL - 14

JO - Frontiers in Neuroscience

JF - Frontiers in Neuroscience

SN - 1662-4548

M1 - 790

ER -

ID: 248497500